Xiaosong Chen
Impact in
- Cancer Research top 1%
- Breast Cancer Treatment Studies
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
Papers in
-
- Breast Cancer Treatment Studies 61
- Oncology 58
- HER2/EGFR in Cancer Research 25
- Cancer Treatment and Pharmacology 9
- Cancer Risks and Factors 8
- Cancer Cells and Metastasis 7
- Cancer Immunotherapy and Biomarkers 7
- Co-authors
- Kunwei Shen (129 shared papers)Ou Huang (57 shared papers)Jiayi Wu (57 shared papers)Xiaochun Fei (33 shared papers)Qing Qu (7 shared papers)Shuning Ding (8 shared papers)Weiguo Chen (52 shared papers)Yan Mao (10 shared papers)
- Journals
- Frontiers in Oncology (14 papers)Breast Cancer Research and Treatment (7 papers)Scientific Reports (6 papers)BMC Cancer (6 papers)Journal of Cancer (6 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Xiaosong Chen
157 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 125
- Cancer Research 1.0k
- Oncology 1.1k
- Radiology, Nuclear Medicine and Imaging 410
- Hepatology 137
- Immunology 311
Countries citing papers authored by Xiaosong Chen
This map shows the geographic impact of Xiaosong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaosong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaosong Chen more than expected).
Fields of papers citing papers by Xiaosong Chen
This network shows the impact of papers produced by Xiaosong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaosong Chen. The network helps show where Xiaosong Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaosong Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 166 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 205 | |
| 2 | 2015 | 198 | |
| 3 | 2014 | 183 | |
| 4 | 2020 | 177 | |
| 5 | 2010 | 119 | |
| 6 | 2017 | 107 | |
| 7 | 2013 | 96 | |
| 8 | 2012 | 92 | |
| 9 | 2012 | 76 | |
| 10 | 2021 | 70 | |
| 11 | 2021 | 64 | |
| 12 | 2013 | 60 | |
| 13 | 2016 | 54 | |
| 14 | 2013 | 51 | |
| 15 | 2020 | 46 | |
| 16 | 2016 | 45 | |
| 17 | 2023 | 44 | |
| 18 | 2021 | 44 | |
| 19 | 2016 | 43 | |
| 20 | 2015 | 42 |
About Xiaosong Chen
Xiaosong Chen is a scholar working on Cancer Research, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 166 papers that have together received 3.4k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (61 papers), HER2/EGFR in Cancer Research (25 papers), Advanced Breast Cancer Therapies (10 papers), Cancer Treatment and Pharmacology (9 papers), Breast Lesions and Carcinomas (9 papers), Cancer Risks and Factors (8 papers), Cancer Cells and Metastasis (7 papers) and Cancer Immunotherapy and Biomarkers (7 papers). The work is most often cited by research in Cancer Research (1.0k citations), Oncology (1.1k citations), Radiology, Nuclear Medicine and Imaging (410 citations), Hepatology (137 citations) and Immunology (311 citations). Xiaosong Chen has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Kunwei Shen, Ou Huang, Jiayi Wu, Xiaochun Fei, Qing Qu, Shuning Ding, Weiguo Chen, Yan Mao, Yafen Li and Jianrong He. Their work appears in journals such as Frontiers in Oncology, Breast Cancer Research and Treatment, Scientific Reports, BMC Cancer and Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.